PTSD Clinical Trial
Official title:
Post Traumatic Stress Disorder Among VA Ambulatory Care Patients
Posttraumatic stress disorder (PTSD) occurs in response to an extreme traumatic stressor. It is estimated that as many as 1 million VA patients who were exposed to combat may have PTSD. VA patients with PTSD recently have been designated as a �Special Emphasis� population for which health care resources are allocated at approximately 14 times those allocated to patients without such chronic, complex, and intensive health care needs (i.e., �Basic Care� groups). Despite recognition of its substantial impact upon VA resources, the extent and means by which PTSD affects health and health care use remain unclear. This study seeks to enhance understanding of both the extent and means by which PTSD affects the health and the health care use of patients in VA ambulatory care. To meet this goal, we build on an ongoing HSR&D project, the Veterans Health Study (VHS), a prospective longitudinal study of 2,425 VA ambulatory care patients.
Background:
Posttraumatic stress disorder (PTSD) occurs in response to an extreme traumatic stressor. It
is estimated that as many as 1 million VA patients who were exposed to combat may have PTSD.
VA patients with PTSD recently have been designated as a �Special Emphasis� population for
which health care resources are allocated at approximately 14 times those allocated to
patients without such chronic, complex, and intensive health care needs (i.e., �Basic Care�
groups). Despite recognition of its substantial impact upon VA resources, the extent and
means by which PTSD affects health and health care use remain unclear. This study seeks to
enhance understanding of both the extent and means by which PTSD affects the health and the
health care use of patients in VA ambulatory care. To meet this goal, we build on an ongoing
HSR&D project, the Veterans Health Study (VHS), a prospective longitudinal study of 2,425 VA
ambulatory care patients.
Objectives:
Posttraumatic stress disorder (PTSD) often afflicts victims of traumatic events such as
combat. Growing evidence suggests that PTSD is related to poorer health status and to
increased use of health care services. However, the extent of these effects and the means by
which they occur remain unclear. The goal of this study is to enhance our understanding of
both the extent and means by which PTSD affects the health and the health care use of
patients in VA ambulatory care. To meet this goal, we built on an HSR&D service-directed
project, the Veterans Health Study (VHS), a prospective longitudinal study of 2,425 male VA
ambulatory care patients.
Methods:
This project consisted of two phases. In Phase 1, we conducted clinical interviews (CAPS)
assessing PTSD with 474 patients participating in the VHS at 1-year follow-up (T12). This
phase validated a brief 17-item self-report PTSD screening measure (PCL-C) against a PTSD
clinical interview diagnosis. We used the results of this validation study to estimate the
prevalence of PTSD in VA primary care, and to propose the use of a brief measure (PRIME-MD)
as a screen for PTSD in primary care. In Phase 2, we used the PCL-C to examine the impact of
PTSD on health status and health care use. We tested the hypotheses that (a) PTSD has a
direct effect on health status that is independent of the effects of comorbid medical
conditions, depression, and alcohol use, and (b) that controlling for comorbid medical
conditions, depression and alcohol use, PTSD has both a direct effect and an indirect effect
(through health status) on health care utilization. These hypotheses are being tested using
structural equation methods. If, as hypothesized, PTSD exerts direct and indirect effects on
health services use, then both quality of care and efficiencies in health services delivery
can be improved through appropriate detection, referral, and treatment of PTSD among
patients in VA ambulatory care.
Status:
Completed.
;
Time Perspective: Prospective
Status | Clinical Trial | Phase | |
---|---|---|---|
Active, not recruiting |
NCT03962504 -
Written Exposure Therapy Versus Prolonged Exposure: a Non-inferiority Trial
|
N/A | |
Completed |
NCT01995123 -
Behavioral Activation for Smoking Cessation in PTSD
|
N/A | |
Not yet recruiting |
NCT06278922 -
Evaluating Signs of Safety: A Deaf-Accessible Therapy Toolkit for AUD and Trauma
|
N/A | |
Completed |
NCT04597450 -
Lu AG06466 in Participants With Post Traumatic Stress Disorder (PTSD)
|
Phase 1 | |
Completed |
NCT03593772 -
Mission Reconnect- Delivering a Mobile and Web Based Self Directed Complementary And Integrative Health Program to Veterans and Their Partners to Manage Pain and PTSD
|
N/A | |
Completed |
NCT03429166 -
Connecting Women to Care: Home-based Psychotherapy for Women With MST Living in Rural Areas
|
N/A | |
Recruiting |
NCT04317820 -
Deep Brain Reorienting in Post-traumatic Stress Disorder
|
N/A | |
Active, not recruiting |
NCT04588883 -
Strengthening Families Living With HIV in Kenya
|
N/A | |
Completed |
NCT03504722 -
Evaluating the Feasibility of RESCUE: An Adjunctive HAI-Based Intervention for Veterans With PTSD
|
N/A | |
Completed |
NCT04305353 -
Intensive Care Unit (ICU) Diary Project
|
N/A | |
Completed |
NCT03113890 -
McLean and Genomind Prospective Study
|
N/A | |
Withdrawn |
NCT05173831 -
Study of Feasibility and Safety of MDMA-Assisted Group Therapy for the Treatment of PTSD in Veterans
|
Phase 2 | |
Withdrawn |
NCT03924297 -
Chilipad for Sleep and Symptoms of PTSD
|
N/A | |
Not yet recruiting |
NCT04056767 -
Changes in Digital Phenotype During PE Therapy
|
||
Withdrawn |
NCT03216356 -
Effect of D-cycloserine on a Short Imagery Rescripting Intervention for Subclinical PTSD
|
Phase 2/Phase 3 | |
Completed |
NCT03158558 -
Intensive Weekend Retreat Multi-Couple Group Therapy for PTSD
|
N/A | |
Completed |
NCT03343028 -
Biomarker Establishment for Superior Treatment of PTSD
|
||
Completed |
NCT02370173 -
A Non-Pharmacological Method for Enhancing Sleep in PTSD
|
N/A | |
Withdrawn |
NCT01957371 -
Mindful Yoga Therapy for Veterans With PTSD and Pain
|
N/A | |
Completed |
NCT01911585 -
Efficacy of 60-minute Versus 90-minute Sessions in Treating PTSD Using Prolonged Exposure
|
N/A |